Koers High Hampton Holdings Corp Canadian Securities Exchange
Aandelen
CA42966X2005
Farmaceutische producten
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 563K 411K 383K |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | - 0 0 | Nettowinst (verlies) 2023 | - 0 0 | EV/omzet 2022 | - |
Nettoliquiditeiten 2022 | 841K 614K 571K | Nettoliquiditeiten 2023 | 690K 504K 469K | EV/omzet 2023 | - |
K/w-verhouding 2022 |
22,9
x | K/w-verhouding 2023 |
-8,18
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 79,53% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Robert Dubeau
CEO | Chief Executive Officer | - | 26-09-23 |
Director of Finance/CFO | 53 | 19-09-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director of Finance/CFO | 53 | 19-09-23 | |
Robert Dubeau
CEO | Chief Executive Officer | - | 26-09-23 |
Anderson Shannon
BRD | Director/Board Member | - | 19-09-23 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+21,85% | 546 mld. | |
-4,77% | 359 mld. | |
+16,97% | 323 mld. | |
+5,69% | 290 mld. | |
+13,68% | 234 mld. | |
+3,65% | 198 mld. | |
-11,12% | 194 mld. | |
+8,08% | 167 mld. | |
-3,40% | 157 mld. |